title: Clinical interest of KRAS mutation detection in blood for anti-EGFR therapies in metastatic colorectal cancer.
authors.forename: F
authors.initials: F
authors.lastname: Di Fiore
authors.forename: F
authors.initials: F
authors.lastname: Charbonnier
authors.forename: B
authors.initials: B
authors.lastname: Lefebure
authors.forename: M
authors.initials: M
authors.lastname: Laurent
authors.forename: F
authors.initials: F
authors.lastname: Le Pessot
authors.forename: P
authors.initials: P
authors.lastname: Michel
authors.forename: T
authors.initials: T
authors.lastname: Frebourg
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D015179:Colorectal Neoplasms / Q000097:blood* / Q000188:drug therapy* / Q000473:pathology; D066246:ErbB Receptors / Q000037:antagonists & inhibitors*; D011905:Genes, ras; D006801:Humans; D009154:Mutation; D009362:Neoplasm Metastasis
chemical_list: D000970:Antineoplastic Agents; D066246:ErbB Receptors